Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Total Assets

Acadia Pharmaceutica Total Assets Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Total Assets from 2010 to 2020.
  • Acadia Pharmaceutica Total Assets for the quarter ending June 06, 2020 was $760m a -0.78% decrease of -6m year over year
  • Acadia Pharmaceutica Total Assets for the last 12 months ending June 06, 2020 was $760m a -0.78% decrease of -6m year over year
  • Acadia Pharmaceutica Annual Total Assets for 2019 was $783m a 31.02% increase of 243m from 2018
  • Acadia Pharmaceutica Annual Total Assets for 2018 was $540m a 28.82% increase of 156m from 2017
  • Acadia Pharmaceutica Annual Total Assets for 2017 was $385m a -45.94% decrease of -177m from 2016
Other Balance Sheet Metrics:
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Equity for the quarter ending September 09, 2018 was $223m a -50.06% decrease of -112m year over year
View Chart On Koyfin

Quarterly ACAD Total Assets Data

06/2020$760m
03/2020$747m
12/2019$783m
09/2019$766m
06/2019$461m
03/2019$501m
12/2018$540m
09/2018$266m
06/2018$315m
03/2018$351m

Annual ACAD Total Assets Data

2019$783m
2018$540m
2017$385m
2016$561m
2015$222m
2014$325m
2013$189m
2012$109m
2011$32m
2010$38m